Techniques and Safety Issues for Intraperitoneal Chemotherapy

Santiago González-Moreno; Gloria Ortega-Pérez; Oscar Alonso-Casado; Javier Galipienzo-García; Manuel J Linero-Noguera; David Salvatierra-Díaz

doi:10.1016/j.soc.2018.02.005

Techniques and Safety Issues for Intraperitoneal Chemotherapy

Surg Oncol Clin N Am. 2018 Jul;27(3):495-506. doi: 10.1016/j.soc.2018.02.005.

Authors

Santiago González-Moreno¹, Gloria Ortega-Pérez², Oscar Alonso-Casado³, Javier Galipienzo-García⁴, Manuel J Linero-Noguera⁴, David Salvatierra-Díaz⁴

Affiliations

¹ Peritoneal Surface Oncology Program, Department of Surgical Oncology, MD Anderson Cancer Center, Calle Arturo Soria 270, Madrid 28033, Spain. Electronic address: sgonzalezm@mdanderson.es.
² Peritoneal Surface Oncology Program, Department of Surgical Oncology, MD Anderson Cancer Center, Calle Arturo Soria 270, Madrid 28033, Spain.
³ Hepatobiliary and Pancreatic Surgery, Department of Surgical Oncology, MD Anderson Cancer Center, Calle Arturo Soria 270, Madrid 28033, Spain.
⁴ Department of Anesthesiology, MD Anderson Cancer Center, Calle Arturo Soria 270, Madrid 28033, Spain.

PMID: 29935685
DOI: 10.1016/j.soc.2018.02.005

Abstract

Different techniques for delivering perioperative intraperitoneal chemotherapy have been described, but no significant differences have been found among them. Hyperthermic intraperitoneal chemotherapy (HIPEC) is a safe treatment for the patient and for the health care workers involved in the procedure provided standard protective and environmental measures are employed.

Keywords: Hyperthermia; Intraperitoneal chemotherapy; Occupational hazard; Peritoneal neoplasms; Safety; Technique.

Publication types

Review

MeSH terms

Antineoplastic Agents / administration & dosage*
Antineoplastic Agents / adverse effects*
Chemotherapy, Cancer, Regional Perfusion / adverse effects*
Chemotherapy, Cancer, Regional Perfusion / methods*
Humans
Injections, Intraperitoneal
Peritoneal Neoplasms / drug therapy*
Safety

Substances

Antineoplastic Agents